IXICO announces expansion of collaboration with Biogen

July 24, 2017
News

IXICO announces an expansion of its pilot of the Assessa® PML platform which includes Biogen, a leading company in Multiple Sclerosis, and expert reading institutions.


Download Full Press Release


The AssessaPML digital platform is being piloted in five EU countries as part of a collaborative agreement which was announced on 9 October 2015. The aim is to facilitate the remote transfer, management and storage of MRI scans to more reliably and effectively offer access to reading expertise for the detection of Progressive Multifocal Leukoencephalopathy (“PML”), a rare and potentially fatal disease that affects people living with MS. The pilot, which includes platform development and on-boarding of clinical sites participating in the pilot, has now been expanded to include pharmacovigilance reporting (monitoring the effects of medical drugs in order to identify and evaluate previously unreported adverse reactions).


Download Full Press Release